BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS

BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Vishay Intertechnology Automotive Grade Ambient Light Sensors Deliver Accurate Visible Light Measurement with no IR Bump
• Cushman & Wakefield names two capital markets leaders in APAC